A novel drug called torcetrapib can dramatically increase blood concentrations of high-density lipoprotein (HDL), the beneficial cholesterol, according to a preliminary study. Derived from a trial involving only 19 people, these data paved the way for two much larger studies that are just under way.
Seventeen men and two women took a torcetrapib pill daily for 4 weeks, then an inert pill for 4 more weeks.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.